The estimated Net Worth of Michael F Mahoney is at least $197 Milion dollars as of 5 September 2024. Mr. Mahoney owns over 162,777 units of Boston Scientific stock worth over $134,610,542 and over the last 13 years he sold BSX stock worth over $46,748,968. In addition, he makes $15,764,100 as Chairman of the Board, President a Chief Executive Officer at Boston Scientific.
Michael has made over 79 trades of the Boston Scientific stock since 2012, according to the Form 4 filled with the SEC. Most recently he sold 162,777 units of BSX stock worth $13,212,609 on 5 September 2024.
The largest trade he's ever made was exercising 372,611 units of Boston Scientific stock on 1 January 2015 worth over $30,904,356. On average, Michael trades about 71,082 units every 40 days since 2011. As of 5 September 2024 he still owns at least 1,622,987 units of Boston Scientific stock.
You can see the complete history of Mr. Mahoney stock trades at the bottom of the page.
Michael F. Mahoney serves as Chairman of the Board, President, Chief Executive Officer of the Company. He joined the Company as our President in October 2011, and became our President and Chief Executive Officer and a director in November 2012. Mr. Mahoney became our Chairman of the Board in May 2016. Prior to joining the Company, he was Worldwide Chairman of the Medical Devices and Diagnostics division of Johnson & Johnson from January 2011 to September 2011, overseeing 50,000 employees and seven franchises. Prior to assuming this position, Mr. Mahoney served as Worldwide Group Chairman of Johnson & Johnson's DePuy franchise, an orthopedics and neurosciences business, from April 2007 through January 2011. From January 2001 through March 2007, Mr. Mahoney served as President and Chief Executive Officer of Global Healthcare Exchange, a provider of supply chain solutions and services that brings together hospitals, manufacturers, distributors and group purchasing organizations. Mr. Mahoney began his career at General Electric Medical Systems, where he spent 12 years, culminating in the role of General Manager of the Healthcare Information Technology business.
As the Chairman of the Board, President a Chief Executive Officer of Boston Scientific, the total compensation of Michael Mahoney at Boston Scientific is $15,764,100. There are no executives at Boston Scientific getting paid more.
Michael Mahoney is 55, he's been the Chairman of the Board, President a Chief Executive Officer of Boston Scientific since 2016. There are 16 older and 10 younger executives at Boston Scientific. The oldest executive at Boston Scientific Corp. is Yoshiaki Fujimori, 69, who is the Independent Director.
Michael's mailing address filed with the SEC is 300 BOSTON SCIENTIFIC WAY, , MARLBOROUGH, MA, 01752-1234.
Over the last 19 years, insiders at Boston Scientific have traded over $938,841,783 worth of Boston Scientific stock and bought 1,398,972 units worth $16,231,539 . The most active insiders traders include Peter M Nicholas, John E Abele a Michael F Mahoney. On average, Boston Scientific executives and independent directors trade stock every 3 days with the average trade being worth of $4,899,929. The most recent stock trade was executed by Michael F Mahoney on 5 September 2024, trading 162,777 units of BSX stock currently worth $13,212,609.
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.
Boston Scientific executives and other stock owners filed with the SEC include: